france

GENESIS MAGMA RACING UNVEILS ROADMAP TO 2026 DEBUT AT LE MANS

Team Principal Cyril Abiteboul announces key appointments during press conference at Circuit de la SartheGenesis announces brand entry into France,…

1 month ago

GENESIS ANNOUNCES MAJOR EUROPEAN MARKET EXPANSION AT LE MANS

Genesis Motor Europe will expand operations into four new marketsThe Korean car brand will launch in France, Italy, Spain and…

1 month ago

GENESIS MAGMA RACING TRAJECTORY DRIVER JAMIE CHADWICK TALKS RACE STRATEGY, HYPERCAR AMBITIONS

Le Mans, France, Thursday 12th June: As a three-time W Series champion and the only female driver to win a…

1 month ago

ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025

ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025 NANTES, France, June 11, 6:30 PM – OSE Immunotherapeutics…

1 month ago

The Hashemite Kingdom of Jordan Announces New Ocean Innovation Hub in Partnership with Innovative Blue Technology Company Voyacy Regen

Located in the Gulf of Aqaba, in the Hashemite Kingdom of Jordan, the Aqaba Marine Park will focus on building…

2 months ago

Dassault Systmes: declaration of the number of outstanding shares and voting rights as of May 31, 2025

Press ReleaseVELIZY-VILLACOUBLAY, France — June 9, 2025                 Declaration of the number of outstanding shares and voting rights as of May…

2 months ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Saint-Herblain (France), June 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today…

2 months ago

Maxim Group initiates the coverage of the CROSSJECT share with a BUY recommendation and a target price of 4.00

Press release Maxim Group initiates the coverage of the CROSSJECT share with a BUY recommendation and a target price of…

2 months ago

Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde regimen in metastatic pancreatic adenocarcinoma

Phase III NAPOLI 3 trial is the largest and has the longest follow-up for an interventional study in metastatic pancreatic…

2 months ago